Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

TB Guidelines

Treatment

Title	Format
Treatment of Drug-Susceptible Tuberculosis Clinical Infectious Disease 2016 Highlights from the 2016 Treatment of Drug-Susceptible Tuberculosis Guidelines	PDF (1 MB)
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis June 2013	PDF (492 KB)
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis MMWR 2013;62 (No. 9)	PDF (411 KB)
Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection MMWR 2011;60:1650–1653	PDF (1.1 MB)
Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC MMWR 2005; 54 (No. RR-15, 1-37)	PDF (544 KB)
MMWR: Errata: Treatment of Tuberculosis (Vol. 52, No. RR-11)	PDF (499 KB)
Treating Opportunistic Infections Among HIV-Exposed and Infected Children MMWR 2004; 53 (RR14)	PDF (742 KB)
Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor - Alpha – California, 2002–2003 MMWR 2004; 53 (No. 30)	PDF (325 KB)
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2004; 53 (No. 2)	PDF (349 KB)
Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection MMWR 2003; 52 (No. 31).	PDF (587 MB)
Treatment of Tuberculosis MMWR 2003; 52 (No. RR-11) Errata	PDF (1.5 MB) PDF (499 KB)
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection MMWR 2000; 49 (No. RR-6) Updates	PDF (350 KB)
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors MMWR 2000; 49 (No. 9)	PDF (241 KB)

Archived Treatment

The documents listed below are historical, archived information. The information contained in these documents, while accurate at the time of release, may not be the most current available.

Title	Format
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis MMWR 2008; 57 (No. 04, 98)	PDF (277 KB)
Public Health Dispatch: Update: Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection MMWR 2002; 51 (No. 44)	PDF (1.7 MB)
Management of Persons Exposed to Multidrug-Resistant Tuberculosis MMWR 1992; 41 (RR-11)

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed: May 4, 2016
Page last updated: November 2, 2016
Content source:
- Division of Tuberculosis Elimination

Top